Syros Pharmaceuticals Inc (LTS:0LC7) Transcripts
Q3 2024 Syros Pharmaceuticals Inc Earnings Call Transcript
Oct 31, 2024
$2.53
(+0.80%)
Earnings
Q2 2024 Syros Pharmaceuticals Inc Earnings Call Transcript
Jul 31, 2024
$6.23
(-1.22%)
Earnings
Q1 2024 Syros Pharmaceuticals Inc Earnings Call Transcript
May 14, 2024
$5.1
Earnings
Q4 2023 Syros Pharmaceuticals Inc Earnings Call Transcript
Mar 27, 2024
$5.67
(-9.80%)
Earnings
Syros Pharmaceuticals Inc Conference Call Transcript
Dec 06, 2023
Q3 2023 Syros Pharmaceuticals Inc Earnings Call Transcript
Nov 14, 2023
$2.61
(-15.53%)
Earnings
Q2 2023 Syros Pharmaceuticals Inc Earnings Call Transcript
Aug 08, 2023
$3.69
(+3.51%)
Earnings
Syros Pharmaceuticals Inc Annual Shareholders Meeting Transcript
Jun 01, 2023
Syros Pharmaceuticals Inc at JMP Securities Life Sciences Conference Transcript
May 16, 2023
Q1 2023 Syros Pharmaceuticals Inc Earnings Call Transcript
May 10, 2023
$3.55
(+11.57%)
Earnings
Q4 2022 Syros Pharmaceuticals Inc Earnings Call Transcript
Mar 02, 2023
$3.61
(-4.44%)
Earnings
Syros Pharmaceuticals Inc to Discuss Ongoing Phase 2 SELECT-AML-1 Clinical Trial Transcript
Dec 10, 2022
Q3 2022 Syros Pharmaceuticals Inc Earnings Call Transcript
Nov 14, 2022
$3.91
Earnings
Q2 2022 Syros Pharmaceuticals Inc Earnings Call Transcript
Aug 09, 2022
$8.36
Earnings
Syros Pharmaceuticals Inc to Acquire TYME Technologies Inc Call Transcript
Jul 05, 2022
Syros Pharmaceuticals Inc at JMP Securities Life Sciences Conference Transcript
Jun 15, 2022
Q1 2022 Syros Pharmaceuticals Inc Earnings Call Transcript
May 16, 2022
$8
Earnings
Q4 2021 Syros Pharmaceuticals Inc Earnings Call Transcript
Mar 15, 2022
$11.85
Earnings
Q3 2021 Syros Pharmaceuticals Inc Earnings Call Transcript
Nov 05, 2021
$44.85
(+2.28%)
Earnings
Syros Pharmaceuticals Inc at ESMO Congress Conference Call Transcript
Sep 20, 2021
Q2 2021 Syros Pharmaceuticals Inc Earnings Call Transcript
Aug 05, 2021
$45.35
(-9.12%)
Earnings
Syros Pharmaceuticals Inc SY-2101 in APL-Call Transcript
Jul 20, 2021
Syros Pharmaceuticals Inc SY-1425 in Newly Diagnosed Unfit AML-Call Transcript
Jun 22, 2021
Syros Pharmaceuticals Inc Annual Shareholders Meeting Transcript
Jun 08, 2021
Syros Pharmaceuticals Inc SY-1425 in Newly Diagnosed HR-MDS - Corporate Call Transcript
May 26, 2021
Q1 2021 Syros Pharmaceuticals Inc Earnings Call Transcript
May 06, 2021
$53
(-12.42%)
Earnings
Syros Pharmaceuticals Inc at Oppenheimer Healthcare Conference (Virtual) Transcript
Mar 16, 2021
Q4 2020 Syros Pharmaceuticals Inc Earnings Call Transcript
Mar 04, 2021
$96.9
Earnings
Syros Pharmaceuticals Inc at JPMorgan Healthcare Conference (Virtual) Transcript
Jan 14, 2021
Syros Pharmaceuticals Inc New Data From Phase 2 Clinical Trial of SY-1425 and Plans to Initiate Registration-Enabling Trial in MDS and Randomized Phase 2 Trial in AML Call Transcript
Dec 05, 2020
Q3 2020 Syros Pharmaceuticals Inc Earnings Call Transcript
Nov 05, 2020
$133.59
Earnings
Q2 2020 Syros Pharmaceuticals Inc Earnings Call Transcript
Aug 06, 2020
$70
Earnings
Q1 2020 Syros Pharmaceuticals Inc Earnings Call Transcript
May 07, 2020
$70
Earnings
Q4 2019 Syros Pharmaceuticals Inc Earnings Call Transcript
Mar 05, 2020
$70
Earnings
Q3 2019 Syros Pharmaceuticals Inc Earnings Call Transcript
Nov 12, 2019
$70
Earnings
Syros Pharmaceuticals Inc to Announce Update on Selective CDK7 Inhibitor Portfolio Call Transcript
Oct 17, 2019
Q2 2019 Syros Pharmaceuticals Inc Earnings Call Transcript
Aug 01, 2019
$70
Earnings
Q1 2019 Syros Pharmaceuticals Inc Earnings Call Transcript
May 01, 2019
$129.7
Earnings
Q4 2018 Syros Pharmaceuticals Inc Earnings Call Transcript
Mar 07, 2019
$129.7
Earnings